Skip to main content

Circle of Support

Our Initiatives

MNPQC is working with community partners and leaders to improve outcomes in the following areas. Our initiatives are reviewed and recommended by the Program Advisory Committee based on the needs of Minnesota families, evidence-based research, and the ability to make sustainable change.


Mother/Infant Opioid Substance Use Treatment and Recovery Effort

The MOSTaRE Initiative launched in September 2022 and emphasizes family-centered care that maintains the maternal-infant dyad. It addressed treatment and prevention of substance exposure during pregnancy for mother and infant. After the completion of the first year, teams entered a maintenance phase of quarterly calls scheduled until October 2024. This Initiative satisfies new CMS guidelines for hospitals to collaborate with state PQCs. Tentative 2nd Cohort and other collaborative opportunities around this work will be available in 2024- more information to come! Please make sure you are receiving our newsletter for updates as dates become available.

EHDI: Timely Diagnosis Initiative

Early Hearing Detection and Intervention (EHDI)

This Initiative was implemented in February 2023. The Aim is to improve the percentage of newborns with refer/did not pass newborn hearing screening from birthing facilities and received a complete audiological hearing evaluation by 3 months of age.

Hypertension in Pregnancy

In 2021 MNPQC hosted a statewide quality improvement initiative to improve the identification, treatment, and follow up of hypertension in pregnancy and the postpartum period. Information/resources on this work is found here.

Preterm Birth Prevention

Prematurity is now the leading cause of infant death in Minnesota and is associated with 33.1% of infant deaths from 2016-2020.

Top of Page

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.